NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | -9.0% | 1,614 | 0.0% | 0.00% | – |
| Q2 2023 | $78 | -12.4% | 1,614 | 0.0% | 0.00% | – |
| Q1 2023 | $89 | +30.9% | 1,614 | -4.9% | 0.00% | – |
| Q4 2022 | $68 | -99.9% | 1,698 | -36.9% | 0.00% | – |
| Q3 2022 | $117,000 | +24.5% | 2,693 | +0.1% | 0.00% | – |
| Q2 2022 | $94,000 | +28.8% | 2,691 | +48.4% | 0.00% | – |
| Q1 2022 | $73,000 | -43.4% | 1,813 | +30.4% | 0.00% | – |
| Q4 2021 | $129,000 | +38.7% | 1,390 | +66.3% | 0.00% | – |
| Q3 2021 | $93,000 | -89.1% | 836 | -88.9% | 0.00% | -100.0% |
| Q2 2021 | $851,000 | -70.6% | 7,508 | -73.7% | 0.00% | -75.0% |
| Q1 2021 | $2,899,000 | -20.0% | 28,557 | -21.6% | 0.00% | -20.0% |
| Q4 2020 | $3,624,000 | +3318.9% | 36,421 | +1602.7% | 0.01% | – |
| Q2 2020 | $106,000 | +41.3% | 2,139 | -4.6% | 0.00% | – |
| Q4 2019 | $75,000 | +341.2% | 2,242 | +314.4% | 0.00% | – |
| Q3 2019 | $17,000 | -99.0% | 541 | -99.6% | 0.00% | -100.0% |
| Q3 2015 | $1,637,000 | – | 150,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |